Selvakumar Elangovan
Overview
Explore the profile of Selvakumar Elangovan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kundu G, Elangovan S
Biomedicines
. 2025 Jan;
13(1.
PMID: 39857756
: Cancer is caused by disruptions in the homeostatic state of normal cells, which results in dysregulation of the cell cycle, and uncontrolled growth and proliferation in affected cells to...
2.
Mitra T, Prusty M, Elangovan S
Comput Biol Chem
. 2024 Nov;
113:108280.
PMID: 39571453
Cervical cancer is one of the most prevalent female reproductive cancers. miR-21 is a multi-target oncomiR that has shown its potential in regulating several cancers including colon, pancreatic, breast, prostate,...
3.
Sheeraz A, Aiswarya E, Kumara B, Sonia J, Rodrigues R, Sheikh N, et al.
Analyst
. 2024 Jul;
149(15):3882-3890.
PMID: 38973472
Nowadays, kidney dysfunction is a common health issue due to the modernized lifestyle. Even though medications are commercially available to treat kidney diseases, early diagnosis is crucial and challenging. Clinically,...
4.
Kumar Mahanta S, Pratikshya Nayak P, Muduli K, Elangovan S, Paramasivan S, Mallick P, et al.
Methods
. 2024 Jun;
229:30-40.
PMID: 38880434
The objective of this study was to optimise the millet formulation using Levilactobacillus brevis and to evaluate its anticarcinogenic potential in vitro. The formula was developed in the course of...
5.
Sahu W, Bai T, Das A, Mukherjee S, Prusty A, Mallick N, et al.
FEBS Lett
. 2024 Feb;
598(7):818-836.
PMID: 38418371
Plasmodium falciparum renovates the host erythrocyte to survive during intraerythrocytic development. This renovation requires many parasite proteins to unfold and move outside the parasitophorous vacuolar membrane, and chaperone-regulated protein folding...
6.
Muduli K, Pradhan J, Prusty M, Samal A, Reddy K, Elangovan S
Med Oncol
. 2024 Feb;
41(3):78.
PMID: 38393411
Breast cancer progression, metastasis and recurrence are largely driven by breast cancer stem cells (BCSCs), which constitute a subset of tumor cells exhibiting stem cell characteristics. In this study, we...
7.
Upreti S, Muduli K, Pradhan J, Elangovan S, Samant M
Med Oncol
. 2023 Oct;
40(11):326.
PMID: 37806999
Breast cancer is the most prevalent form of cancer in women globally, and TNBC (triple-negative breast cancer) is its aggressive type since it lacks the usual targets. JAK2/STAT3 pathway can...
8.
Muduli K, Prusty M, Pradhan J, Samal A, Sahu B, Roy D, et al.
Stem Cell Rev Rep
. 2023 Aug;
19(8):2807-2819.
PMID: 37584854
Cancer stem cells drive tumor initiation, invasion, metastasis and recurrence. In the present study, we have evaluated the role of ERRα in the maintenance of breast cancer stem cells (BCSCs)...
9.
Dey S, Gaur M, Sykes E, Prusty M, Elangovan S, Dixit S, et al.
Genes (Basel)
. 2023 May;
14(5).
PMID: 37239397
Background: The high prevalence and rapid emergence of antibiotic resistance in high-risk ST147 clones is a global health concern and warrants molecular surveillance. Methods: A pangenome analysis was performed using...
10.
Baral B, Muduli K, Jakhmola S, Indari O, Jangir J, Rashid A, et al.
IEEE J Biomed Health Inform
. 2023 Apr;
27(6):2782-2793.
PMID: 37023159
During COVID-19 pandemic qRT-PCR, CT scans and biochemical parameters were studied to understand the patients' physiological changes and disease progression. There is a lack of clear understanding of the correlation...